@article{80a426246a6645aa8994d9294e3aa59a,
title = "Neurofilaments in blood: (Almost) facing clinical application",
author = "Mielke, {Michelle M.} and Markus Otto",
note = "Funding Information: Dr. Mielke served as a consultant to Eli Lilly and Lysosomal Therapeutics, Inc. She receives research support from the NIH (R01 AG49704, P50 AG44170, U01 AG06786, RF1 AG55151), Department of Defense (W81XWH-15-1), and unrestricted research grants from Biogen, Roche, and Lundbeck. Dr. Otto served as consultant for Biogen and Axon. He receives research funding from the European commission (Fairpark-II), German Federal Ministry of Education and Research (KNDD-FTLDc), JPND (Prefrontals), Thierry Latran foundation, Foundation of the state Baden-Wuerttemberg, Boehringer Ingelheim Ulm University BioCenter (BIU), and German Research Foundation (SFB 1279). Go to Neurology.org for full disclosures.",
year = "2017",
doi = "10.1212/WNL.0000000000004675",
language = "English (US)",
volume = "89",
pages = "2126--2127",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "21",
}